Personalis to Present at the 2021 Bank of America Healthcare Conference

Rhea-AI Summary

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced cancer genomics, will present at the 2021 Bank of America Healthcare Conference on May 13, 2021, at 5:00 p.m. Eastern Time. Renowned for its population sequencing and cancer genomics innovations, Personalis operates one of the largest sequencing programs globally, serving the U.S. Department of Veterans Affairs Million Veterans Program. Their ImmunoID NeXT Platform provides comprehensive molecular data on cancer and immune responses, enhancing next-generation therapy development.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the 2021 Bank of America Healthcare Conference on Thursday, May 13, 2021 at 5:00 p.m. Eastern Time.

About Personalis, Inc.

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing programs globally and is currently the sole sequencing provider to the U.S. Department of Veterans Affairs Million Veterans Program. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis^® ImmunoID NeXT Platform^® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue or blood sample. The Personalis^® Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005154/en/

FAQ

When will Personalis present at the Bank of America Healthcare Conference?

Personalis will present on May 13, 2021, at 5:00 p.m. Eastern Time.

What is Personalis known for in cancer genomics?

Personalis is recognized for its advanced population sequencing and as a leading provider of cancer genomics data.

What is the ImmunoID NeXT Platform by Personalis?

The ImmunoID NeXT Platform provides comprehensive molecular data on approximately 20,000 human genes and the immune system from a single tissue or blood sample.

Who is the primary client for Personalis's sequencing services?

Personalis is the sole sequencing provider for the U.S. Department of Veterans Affairs Million Veterans Program.

Is Personalis's Clinical Laboratory certified?

Yes, Personalis's Clinical Laboratory is GxP aligned, CLIA’88-certified, and CAP-accredited.